cover
Contact Name
Budi Hidayat
Contact Email
jurnal.eki@cheps.or.id
Phone
+6281779151002
Journal Mail Official
jurnal.eki@cheps.or.id
Editorial Address
Department of Health and Policy, Building F Floor 1, Faculty of Public Health Universitas Indonesia, Kampus Baru UI Depok 16424, Depok City, West Java Province, Indonesia
Location
Kota depok,
Jawa barat
INDONESIA
Jurnal Ekonomi Kesehatan Indonesia
Published by Universitas Indonesia
ISSN : 25278878     EISSN : 25983849     DOI : https://doi.org/10.7454/eki
This journal encompasses original research articles, case studies, conceptual fields, review-based studies (very limited, it will be strictly selected), and protocols. The journal publishes research from various topics in health economics, including but is not limited to the following topics: Economic Evaluation Health Financing Health Policy Health Insurance Pharmacoeconomics Health Technology Assessment (HTA) Tobacco Control Jaminan Kesehatan Nasional (JKN) Health and Econometric Article published in Jurnal Ekonomi Kesehatan Indonesia are determined through the blind review process conducted by the editor and reviewers. They provide evaluation and constructive suggestions for the authors. Prior to be accepted, they considers several factors such as whether the manuscript format is in accordance with the manuscript template and writing guidelines for authors, the relevance of the article with scopes, and its contribution to the development of health economics evaluation and accounting practices as well as the health policy.
Articles 5 Documents
Search results for , issue "Vol. 3, No. 1" : 5 Documents clear
Cost Benefit Analysis (CBA) Program Pemberian Makanan Tambahan (PMT) Susu Pada Karyawan di PT. Trisula Textile Industries Tbk Cimahi Tahun 2018 Rahmiyati, Ayu Laili
Jurnal Ekonomi Kesehatan Indonesia Vol. 3, No. 1
Publisher : UI Scholars Hub

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Cost Benefit Analysis (CBA) for the process of identification , measurement,comparison social benefits and cost project or investment program to evaluate utilization of scarce economic resources so that it can be used efficiently .This research purposes are calculateing benefits and cost in rupiah from the milk supplementary feeding program (PMT) at PT. Trisula Textile Industries Tbk Year 2018 and deciding feasibility of program or policy sustainability from PMT milk. The research is using quantitative approach. Data collection is done through interviews, observations, and study documents. Calculation is using Payback Period (PP), Net Present Value (NPV), Internal Rate Of Return (IRR), and Benefit Cost Rate (BCR). The result showscalculation of NPV value on milk PMT program obtained results end Rp. 23,534,448,76, -. To conclude, the milk PMT program is acceptable because NPV> 0. Benefit-cost ratio , is 2.50 (≥ 1), meaning the milk PMT program is feasible. PT. Trisula Textile Industries Tbk is expected to continue the program of milk PMT. Basic research data could be used for preparing health program or health enhancement for employees through PMT or the other priority programs.
Analisis Kesiapan Pembiayaan Hipertensi, Diabetes Melitus dan Gangguan Jiwa dalam Mendukung Program Indonesia Sehat dengan Pendekatan Keluarga (PIS PK) Tahun 2018-2020 Astuti, Trihardini Sri Rejeki; Soewondo, Prastuti
Jurnal Ekonomi Kesehatan Indonesia Vol. 3, No. 1
Publisher : UI Scholars Hub

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Healthy Indonesia Program with Family Approach (PIS PK) is a way to expand Puskesmas reach and access to health services through family home visit Overcoming non-communicable diseases (NCD) is a national priority in achieving Healthy Indonesia because the prevalence of NCD continues to increase. Managing NCD specifically hypertension, Diabetes Mellitus and mental disorders are among the indicators of healthy families in achieving PIS PK.This research uses the qualitative method through in-depth interviews and related document. Analysis of readiness of financing for hypertension, Diabetes Mellitus and mental is calculated using costing methode of SPM. The results indicated health spending for PIS PK activities were utilized for socialization, education and data collection. Referring to SPM costing calculation, the City of Depok was able to implement SPM for hypertension, Diabetes Mellitus and Mental Disorder with using only 1.38% of the total APBD (non-salary). Depok City is not ready in implementing PIS PK, specifically in terms of commitment, human resources, and budget. Though already familiar with PIS PK, Depok City states due to its limited resources, PIS PK implementation depends on the availability of funding from Non-Physical DAK disbursement that tends to have a lengthy lag time between the proposal process and the realization of the disbursement. The financing of PIS PK requires a more optimal planning process and allocation of human resources as needed.
Risk Adjustment of Capitation Payment System: What Can Indonesia Adopt from other Countries? Zahroh, Asri Hikmatuz
Jurnal Ekonomi Kesehatan Indonesia Vol. 3, No. 1
Publisher : UI Scholars Hub

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Capitation calculation in Indonesia is not adjusted by individual and aggregate risk. Without risk adjustment, capitation rates are likely to overpay or underpay primary care. This study aimed to review risk-adjusted capitation payment in other countries for evaluation of capitation payment system in Indonesia. The conduct and reporting of this systematic review followed the recommendations of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). This study used comprehensive electronic search in five databases: Pubmed, Proquest, Scopus, PMC, and EBSCOHost. Search results from five databases in April 2018, yielded a total 19 titles that will continue to review the full article and at the end, 4 articles included for systematic review. Based on risk adjustment of capitation payment system in UK, USA, Canada and Sweden, Indonesia may initiate the use of risk adjustment based on the distribution of age and sex. Then Indonesia can develop risk adjustment based on diagnosis and socioeconomic factors to create more fair and accurate capitation rates for primary care.
Efektivitas Biaya Strategi DOTS Program Tuberkulosis antara Puskesmas dan Rumah Sakit Swasta Kota Depok Ulya, Fikrotul; Thabrany, Hasbullah
Jurnal Ekonomi Kesehatan Indonesia Vol. 3, No. 1
Publisher : UI Scholars Hub

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Global TB notification rate at 2016 was 77% and 46.5% in Southeast Asia. Indonesia last 5 years still remain at 32-33% where Depok City reached 58%. In Depok City, private sector contributed 18.7% of the notified TB case in 2016 although only 40% of private hospitals were involved. The aims of this study is to determine cost-effectiveness of DOTS strategy implementation at private hospital and Public Health Centre (PHC). Comparative study carried out for six months with cohort retrospective between PHC, DOTS and Non DOTS hospitals using 36 samples per group. The calculation of the societal perspective with microcosting based on tariffs, market prices and budget value. Output is Success Rate, where at PHC 86.1%, DOTS hospital 77.78% and Non DOTS hospital 63.89%. The addition cost providers especially person in charge at PHC and DOTS hospital increase success rate. The cost of TB treatment in PHC 42% of private hospital. ACER (Average Cost Effectiveness Ratio) is obtained that the hospital which carry out the DOTS strategy is cost effective. To increase 1% success rate of TB treatment costs Rp 10,084,572 with intervention DOTS programs into a private hospital. An Independen t test stated that cost-effectiveness societal perspectives on TB treatment has a significant difference between PHC, DOTS hospital and Non DOTS hospital .
Economic Evaluation Of Cetuximab for Metastatic Colorectal Cancer (mCRC): A Protocol For Evidence Synthesis Putri, Septiara; Setiawan, Ery; Saldi, Siti Rizny F.; Chandra, Levina; Megraini, Amila; P, Vetty Yulianty
Jurnal Ekonomi Kesehatan Indonesia Vol. 3, No. 1
Publisher : UI Scholars Hub

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Colorectal cancer is fairly common compared to other cancers. The incidence and mortality rates are predicted to increase globally. In some cases, cancer can be potentially spread to another organ or metastatic. One of recent available targeted therapies for metastatic colorectal cancer (mCRC) patient is Cetuximab (Erbitux ®), combined with chemotherapy. Despite clinical effectiveness, there is the importance of the evidence related cost-effectiveness of therapy. This study aims to summary, synthesize, and systematically review the economic evaluation studies of Cetuximab for metastatic colorectal cancer (mCRC). Model based economic evaluation of Cetuximab for metastatic colorectal cancer will be searched and included in the review based on specific eligibility criteria. Several electronic databases that will be used: Medline, Embase, Cochrane, National Institute of Health Research (NIHR) Center for Reviews and Dissemination. Full economic evaluation evidence will be summarized and critically appraised using Drummond as well as (Consolidated Health Economic Evaluation Reporting Standards (CHEERS) checklist. In terms of analysis, we will qualitatively appraise and present the studies that meet our inclusion and exclusion criteria. We are expected to summarize the quality and capture the valuable insights related to health economic evaluation studies of Cetuximab for mCRC patient.

Page 1 of 1 | Total Record : 5